Soligenix, Inc.

Soligenix, Inc. - ROEverified

SNGX

Price:

$0.3995

Market Cap:

$4.12M

Soligenix, Inc., a biopharmaceutical firm in its advanced development stages, concentrates on bringing innovative products to market within the United States, specifically targeting rare illnesses. The company's operations are divided into two main divisions: Specialized BioTherapeutics and Public Health Solutions. Within the Specialized BioTherapeutics division, Soligenix is advancing SGX301 (marketed as HyBryte), a novel photodynamic treatment that has successfully completed its Phase III clinical trials for managing cutaneous T-cell lymphoma. This segment also includes SGX942, an innate defense regulator technology currently undergoing Phase III trials for various inflammatory conditions,...[Read more]

Industry

Biotechnology

IPO Date

1994-04-04

Stock Exchange

NASDAQ

Ticker

SNGX

The ROE as of June 2026 (TTM) for Soligenix, Inc. (SNGX) is -246.04%

According to Soligenix, Inc.’s latest financial reports and current stock price. The company's current ROE is -246.04%. This represents a change of 200.78% compared to the average of -81.80% of the last 4 quarters.

Soligenix, Inc. (SNGX) Historical ROE (quarterly & annually)

How has SNGX ROE performed in the past?

The mean historical ROE of Soligenix, Inc. over the last ten years is -162.56%. The current -246.04% ROE has changed 51.35% with respect to the historical average. Over the past ten years (40 quarters), SNGX's ROE was at its highest in in the December 2022 quarter at 151.91%. The ROE was at its lowest in in the September 2022 quarter at -320.64%.

Quarterly (TTM)
Annual

Average

-162.56%

Median

-171.23%

Minimum

-642.05%

Maximum

558.45%

Soligenix, Inc. (SNGX) ROE by Quarter and Year

Discovering the peaks and valleys of Soligenix, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 353.06%

Maximum Annual ROE = 558.45%

Minimum Annual Increase = -577.10%

Minimum Annual ROE = -642.05%

Quarterly (TTM)
Annual
YearROEChange
2025-209.37%4.30%
2024-200.74%-17.54%
2023-243.45%-143.59%
2022558.45%-577.10%
2021-117.05%-75.24%
2020-472.72%-26.37%
2019-642.05%353.06%
2018-141.72%25.31%
2017-113.09%157.80%
2016-43.87%-100.10%

Soligenix, Inc. (SNGX) Average ROE

How has SNGX ROE performed in the past?

The current ROE of Soligenix, Inc. (SNGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-217.85%

5-year avg

-42.43%

10-year avg

-162.56%

Soligenix, Inc. (SNGX) ROE vs. Peers

How is SNGX’s ROE compared to its peers?

Soligenix, Inc.’s ROE is greater than Ensysce Biosciences, Inc. (-631.47%), greater than Oragenics, Inc. (-177.32%), greater than Can-Fite BioPharma Ltd. (-141.01%), greater than Qualigen Therapeutics, Inc. (-94.09%), greater than Kazia Therapeutics Limited (-116.86%), greater than Xenetic Biosciences, Inc. (-39.28%), greater than Silo Pharma, Inc. (-88.41%), less than Titan Pharmaceuticals, Inc. (1.94%), greater than VYNE Therapeutics Inc. (-69.57%), greater than Clearmind Medicine Inc. (-138.23%),

Build a custom stock screener for Soligenix, Inc. (SNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soligenix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Soligenix, Inc. (SNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Soligenix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Soligenix, Inc.'s ROE?

How is the ROE calculated for Soligenix, Inc. (SNGX)?

What is the highest ROE for Soligenix, Inc. (SNGX)?

What is the 3-year average ROE for Soligenix, Inc. (SNGX)?

What is the 5-year average ROE for Soligenix, Inc. (SNGX)?

How does the current ROE for Soligenix, Inc. (SNGX) compare to its historical average?